), assists to clarify why KIF15 is able to facilitate resistance to Eg5 inhibitors in vivo. MT gliding run by each of those mitotic motors was arrested only once they ended up separately inhibited, lending guidance towards the proposal that a mixture drug therapy concentrating on these motors could